New pill aims to calm agitation at home for schizophrenia and bipolar patients
NCT ID NCT05658510
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 25 times
Summary
This study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 adults took either the drug or a placebo, and researchers measured changes in agitation levels and safety. The goal was to see if the drug could be used safely and effectively at home.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioXcel Clinical Research Site 102
DeSoto, Texas, 75115, United States
-
BioXcel Clinical Research Site 103
Gaithersburg, Maryland, 20877, United States
-
BioXcel Clinical Research Site 104
Orange, California, 92868, United States
-
BioXcel Clinical Research Site 105
Berlin, New Jersey, 08009, United States
-
BioXcel Clinical Research Site 108
Garden Grove, California, 92845, United States
-
BioXcel Clinical Research Site 110
Culver City, California, 90230, United States
-
BioXcel Clinical Research Site 113
Bellflower, California, 90706, United States
-
BioXcel Clinical Research Site 114
Riverside, California, 92506, United States
-
BioXcel Clinical Research Site 117
Lemon Grove, California, 91945, United States
-
BioXcel Clinical Research Site 118
Las Vegas, Nevada, 89102, United States
-
BioXcel Clinical Research Site 121
Los Angeles, California, 90015, United States
-
BioXcel Clinical Research Site 122
Beachwood, Ohio, 44122, United States
-
BioXcel Clinical Research Site 123
Oceanside, California, 92056, United States
-
BioXcel Clinical Research Site 124
Miami, Florida, 33186, United States
-
BioXcel Clinical Research Site 125
Irving, Texas, 75062, United States
-
BioXcel Clinical Research Site 126
Everett, Washington, 98201, United States
-
BioXcel Clinical Research Site 127
Plano, Texas, 75093, United States
-
BioXcel Clinical Research Site 128
Cerritos, California, 90703, United States
-
BioXcel Clinical Research Site 129
Denver, Colorado, 80209, United States
-
BioXcel Clinical Research Site 130
Elgin, Illinois, 60123, United States
-
BioXcel Clinical Research Site 131
Miami, Florida, 33122, United States
-
BioXcel Clinical Research Site 133
Rancho Cucamonga, California, 91730, United States
-
BioXcel Clinical Research Site 136
Austin, Texas, 78754, United States
-
BioXcel Clinical Research Site 137
Las Vegas, Nevada, 89119, United States
Conditions
Explore the condition pages connected to this study.